Clinical neuroscientist; Postdoctoral researcher Lund University; BioFINDER; AMYPAD European IMI project; amyloid PET imaging; disease heterogeneity
Joined August 2019
- Tweets241
- Following216
- Followers477
- Likes1.5K
Lyduine Collij retweeted
The @IMI_AMYPAD Prognostic and Natural History Study has had a successful year💥
Visit our website to get an overview of the data accessibility, a snapshot of 2024, and a glimpse into the future with the #EuroPAD community ⤵️
amypad.eu/news/recent-news/a…
Lyduine Collij retweeted
Today I will be presenting "Use of plasma p-tau217 to identify Aβ-positive cognitively unimpaired participants for clinical trials: A multicohort stud" at @CTADconference (OC-29, 4:40pm CEST).
Lyduine Collij retweeted
🙌Pleased to be part of the first @eumind_congress this week 🇫🇷
Special shout-out to Leo Pieperhoff & @LECollij for showcasing the @IMI_AMYPAD project and its Prognostic and Natural History Study dataset available through the @AlzData #ADWorkbench⤵️
amypad.eu/news/recent-news/a…
➡️Thanks to the data sharing on "Opportunities & Challenges", the landscape of new insights in #neuroimaging did not have any secrets for us! Thank you all for your so amazing talks!! 👏 A focus on #PETimaging will come this afternoon for the 4th symposium, be ready! #EUMIND 🧠
Lyduine Collij retweeted
We had a fantastic day yesterday at the @eumind_congress! If you're attending #EUMind2024, don’t miss @LECollij's presentation today on 'From @IMI_AMYPAD to #EuroPAD – creating a multi-cohort preclinical database to model AD disease trajectories.' #EUMIND
Lyduine Collij retweeted
🚨New publication led by @LECollij ‼️
Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease” shows the exacerbating effects of a-synuclein co-pathology in Alzheimer's disease. Now published in @NatureComms !
nature.com/articles/s41467-0…
Lyduine Collij retweeted
The @IMI_AMYPAD study is advancing research, aiming to improve #Alzheimer’s modelling efforts. This dataset includes cognition data, disease biomarkers, genetic and environmental risk factors, and other relevant variables. bit.ly/ADWorkbench
Lyduine Collij retweeted
#AAIC24 started this morning with an interactive educational session on Amyloid PET Quantification. Thanks to all speakers & delegates🤗
👉Today stop by Poster 88788 from @emmaluckettneu1 "Associations between AD polygenic risk scores & global amyloid deposition in @IMI_AMYPAD"
Lyduine Collij retweeted
If you're joining 🇵🇹#ADPD2024🧠 this week, don't miss the BioFINDER posters and presentations!
#Plasma #asynuclein #ALS #MachineLearning #TauPET #PrimaryCare #SVD #proteomics #sexDifferences #ptau #CSF #biomarkers #Alzheimer and many other topics! 🩸🧬♀️♂️🩺💉
Lyduine Collij retweeted
Excited to share this new preprint! Many thanks to all co-authors and collaborators, @_JakeVogel_ @LECollij @YoungAlexL @RikOssenkoppele @FBarkhof @OskarHansson9, and all not on twitter.
‼️New preprint‼️
🔗Led by PhD student @SEMastenbroek, we unveil three different progression patterns of Lewy body pathology. Disease progression modeling of:
* Postmortem Lewy-type α-synuclein data from 10 🧠 regions
* N=814 donors
👇👇👇
biorxiv.org/content/10.1101/…
Lyduine Collij retweeted
Are you interested in Alzheimer's disease and other dementias, with specific interest in genetics🧬?
Would you like to be part of a team that does cutting-edge research?
We have a post-doc (lu.varbi.com/en/what:job/job…) and a PhD (lu.varbi.com/what:job/jobID:…) position available!
Lyduine Collij retweeted
Attending #EANM23?
Join today the symposium "Preparing for the new era of neuroimaging for Alzheimer's disease symposium" at 13:15 in Hall F2 hosted by @SpringerIME and funded by @EliLillyandCo
@LECollij @FBarkhof @SilviaMorbelli
Lyduine Collij retweeted
Check out our oral communication on Wednesday, October 25!
“Plasma P-tau217 facilitates a two-phase screening approach for participant selection into anti-amyloid trials” @LECollij
ctad-alzheimer.com/program-0
@lunduniversity @amsterdamumc #alzheimer #AD #dementia #brainhealth
Lyduine Collij retweeted
We had the opportunity to share our @IMI_AMYPAD work last week at #AAIC23🧠🗣️🇳🇱
So thankful! We had a fantastic week🤗
@alzassociation @AlzData @LECollij @DavidVallez @JuandoGispert @LuigiLorenzini1 @SEMastenbroek @MehrnazShekari
➡️amypad.eu/news/recent-news/a…
Lyduine Collij retweeted
#AAIC23 Day 4 👋
Come say hello to @SEMastenbroek (Poster #334) and @DavidVallez (Poster #383) to hear more about our @IMI_AMYPAD work.
For more info about our project, visit our website: amypad.eu
Lyduine Collij retweeted
If you want to hear more about pathway-specific polygenic risk scores and amyloid load in our EPAD cohort then come to my #AAIC23 poster tomorrow! I’ll be at P3-003! 🧬 🧠 – at Amsterdam, The Netherlands
Our partners @IMI_EPAD make it possible to access on #ADWorkbench the data, samples and image data from the EPAD Longitudinal Cohort Study. Don't miss their next #AAIC23 presentations and posters on the study, by @LuigiLorenzini1, @LECollij, @emmaluckettneu1 & @craig_ritchie68!
Lyduine Collij retweeted
Good morning #AAIC23! We hold today a Featured Research Session (Clinical Pearl Session) “Towards clinical implementation of Centiloid quantification: Lessons learned from the AMYPAD consortium”.
@MehrnazShekari @LECollij @ariane_blk @JuandoGispert
We hope to see you there!
Lyduine Collij retweeted
Less than 2 weeks to go until #AAIC23! Can't wait to connect and discuss our @IMI_AMYPAD work at the @alzassociation Conference in #Amsterdam.
@JuandoGispert @LECollij @ariane_blk @MehrnazShekari @IHIEurope
➡️amypad.eu/news/recent-news/a…
Lyduine Collij retweeted
Dear dementia and/or PET experts, see the survey below!
Please share your opinions on the future role of tau PET in the clinic and trials through the link 👇
Preliminary results will be presented at #AAIC2023 and eventually published.
Thanks 🙏! alzheimercentrum.nl/the-futu…